Hemospan Improves Outcome in a Model of Perioperative Hemodilution and Blood Loss in the Rat: Comparison With Hydroxyethyl Starch

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 3, 2009, Pages 339-347

  Young, Mark A ^a   Lohman, Jeff ^a   Malavalli, Ashok ^a   Vandegriff, Kim D ^a   Winslow, Robert M ^a,b  

^a SANGART INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

blood substitutes; hemodilution; hemorrhage; Hemospan; MP4

Indexed keywords

HETASTARCH; MALEIMIDE POLYETHYLENE GLYCOL MODIFIED HEMOGLOBIN; PLASMA SUBSTITUTE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD VOLUME; CONTROLLED STUDY; EXCHANGE BLOOD TRANSFUSION; HEART RATE; HEMODILUTION; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ANIMALS; BLOOD SUBSTITUTES; DISEASE MODELS, ANIMAL; HEMODILUTION; HEMOGLOBINS; HETASTARCH; HUMANS; MALE; MALEIMIDES; POLYETHYLENE GLYCOLS; POSTOPERATIVE HEMORRHAGE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 67349085334     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.08.006     Document Type: Article

References (50)

1. Pope A., French G., and Longnecker D.E. Fluid Resuscitation. State of the Science for Treating Combat Casualties and Civilian Injuries (1999), National Academy Press, Washington, DC
2. Moore F.A., McKinley B.A., and Moore E.E. The next generation in shock resuscitation. Lancet 363 (2004) 1988-1996
3. Boldt J. New light on intravascular volume replacement regimens: What did we learn from the past three years?. Anesth Analg 97 (2003) 1595-1604
4. Alderson P., Bunn F., Lefebvre C., et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev CD001208 (2004)
5. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 (2004) 2247-2256
6. Vercueil A., Grocott M.P., and Mythen M.G. Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients. Transfus Med Rev 19 (2005) 93-109
7. Bunn F., Alderson P., and Hawkins V. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev CD001319 (2003)
8. Winslow R.M. αα-Crosslinked hemoglobin: Was failure predicted by preclinical testing?. Vox Sang 79 (2000) 1-20
9. Kramer G., Nascimento P., and Vaid S. Hemoglobin-based oxygen carriers as resuscitative solutions for trauma and combat casualty care. In: Winslow R. (Ed). Blood Substitutes (2006), Inc, London, Elsevier 139-151
10. Winslow R.M. Cell-free oxygen carriers: Scientific foundations, clinical development, and new directions. Biochim Biophys Acta (2008 May 21) [Epub ahead of print]
11. ®) in patients undergoing major orthopedic surgery. Anesthesiology 105 (2006) 1153-1163
12. ®) administered to orthopedic surgery patients with spinal anesthesia. Transfus Med 18 (2008) 28-39
13. Drobin D., Kjellström B., Malm E., et al. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4). J Appl Physiol 96 (2004) 1843-1853
14. 2 therapeutics. Am J Physiol 285 (2003) H1411-H1419
15. Young M., Riddez L., Kjellström T., et al. MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med 33 (2005) 1794-1804
16. Young M.A., Riddez L., Kjellström B.T., et al. Effect of MalPEG-hemoglobin (MP4) on hemodynamics and acid-base status after uncontrolled hemorrhage in anesthetized swine: Comparison with crystalloid and blood. J Trauma 63 (2007) 1234-1244
17. Joshi G.P. Interoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg 101 (2005) 601-605
18. Wiedemann H.P., Wheeler A.P., Bernard G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354 (2006) 2564-2575
19. Winslow R.M., Gonzales A., Gonzales M., et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 85 (1998) 993-1003
20. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC
21. Vandegriff K., Malavalli A., Wooldridge J., et al. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43 (2003) 509-516
22. Migita R., Gonzales A., Gonzales M.L., et al. Blood volume and cardiac index in rats after 50% exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol 82 (1997) 1995-2002
23. Kusuoka H., and Hoffman J.I.E. Advice on statistical analysis for circulation research. Circ Res 91 (2002) 662-671
24. Boldt J. Volume therapy in cardiac surgery: are Americans different from Europeans?. J Cardiothorac Vasc Anesth 20 (2006) 98-105
25. Kohler H., Zschiedrich H., Clasen R., et al. The effects of 500 mL 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl). Anaesthesist 31 (1982) 61-67
26. Khosropour R., Lackner F., Steinbereithner K., et al. Comparison of effects of hydroxyethyl starch (HES 200/0.5) administered pre- and postoperatively in vascular surgery with dextran 40 (60) (author's transl). Anaesthesist 29 (1980) 616-622
27. Waitzinger J., Bepperling F., Pabst G., et al. Effect of a new hydroxyethyl starch (HES) specification [6% HES (130/0.4)] on blood and plasma volumes after bleeding in 12 healthy male volunteers. Clin Drug Invest 17 (1999) 119-125
28. Jacob M., Rehm M., Orth V., et al. Exact measurement of the volume effect of 6% hydroxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution. Anaesthesist 52 (2003) 896-904
29. Winslow R.M., Lohman J., Malavalli A., et al. Comparison of PEG-modified albumin and hemoglobin in extreme hemodilution in the rat. J Appl Physiol 97 (2004) 1527-1534
30. Wilkes N.J., Woolf R., Mutch M., et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 93 (2001) 811-816
31. Doherty D.H., Doyle M.P., Curry S.R., et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 16 (1998) 672-676
32. Johnson P. Local regulation of blood flow. In: Winslow R. (Ed). Blood Substitutes (2006), Inc, London, Elsevier 102-111
33. 2. Am J Physiol Heart Circ Physio 285 (2003) H1600-H1608
34. Cabrales P., and Tsai A. Plasma viscosity regulates systemic and microvascular perfusion during acute extreme anemic conditions. Am J Physiol Heart Circ Physiol 291 (2006) 2445-2452
35. Rohlfs R.J., Bruner E., Chiu A., et al. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 273 (1998) 12128-12134
36. Tsai A.G., Cabrales P., Acharya S., et al. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood 108 (2006) 3603-3610
37. Fitzpatrick C.M., Savage S.A., Kerby J.D., et al. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage. J Am Coll Surg 199 (2004) 693-701
38. Wettstein R., Tsai A., Erni D., et al. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 31 (2003) 1824-1830
39. Kreiter H., Hagen G., Waschke K.F., et al. Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: Effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute. J Cardiothorac Vasc Anesth 11 (1997) 3-9
40. Torres Filho I.P., Spiess B.D., Barbee R.W., et al. Systemic responses to hemodilution after transfusion with stored blood and with a hemoglobin-based oxygen carrier. Anesth Analg 100 (2005) 912-920
41. Ickx B.E., Bepperling F., Melot C., et al. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 91 (2003) 196-202
42. ®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 47 (2000) 1207-1215
43. Kasper S.M., Meinert P., Kampe S., et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 99 (2003) 42-47
44. Langeron O., Doelberg M., Ang E.-T., et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 92 (2001) 855-862
45. Gandhi S.D., Weiskopf R.B., Jungheinrich C., et al. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 106 (2007) 1120-1127
46. Holte K., Sharrock N.E., and Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 89 (2002) 622-632
47. Natanson C., Kern S.J., Lurie P., et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA 299 (2008) 2304-2312
48. Keipert P., Olofsson C., and Winslow R. Letter to the editor: Meta-analysis of the safety profile of hemoglobin-based oxygen carriers. JAMA 300 (2008) 1295-1296
49. Björkholm M., Fagrell B., Przybelski R., et al. A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica 90 (2005) 505-515
50. Vandegriff K., Young M.A., Keipert P., et al. The safety profile of Hemospan: A new oxygen therapeutic designed using maleimide poly(ethylene) glycol conjugation to human hemoglobin. Transfus Altern Transfus Med 9 (2007) 213-225